Condition

Hypofractionated Radiotherapy clinical trials and research

• 5Clinical trials
• 1Country

Newest Hypofractionated Radiotherapy clinical trials

All recruiting trials (5)

• Moderately hypofractionated radiotherapy after hysterectomy for cervical cancer

  This study tests whether a shorter, moderately intensified radiotherapy course after surgery is safe and effective for patients with cervical cancer.

  Recruiting at 2 sites Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality and 1 other locations · NCT07684508

• Platinum-doublet chemotherapy followed by large-fraction radiotherapy with tislelizumab for advanced non-squamous NSCLC

  We will try platinum-based doublet chemotherapy followed by large-fraction radiotherapy together with tislelizumab in people with stage IIIB/C–IV non-squamous non-small cell lung cancer who cannot tolerate concurrent chemoradiotherapy.

  Recruiting Phase 2 Zibo Municipal Hospital · Zibo, Shandong · NCT07198217

• Short-course radiotherapy plus immunochemotherapy before surgery for gastroesophageal junction cancer

  This will test whether giving short-course (hypofractionated) radiotherapy together with a PD-1 drug (serplulimab) and TS-1 chemotherapy before surgery helps people with locally advanced, resectable gastroesophageal junction adenocarcinoma.

  Recruiting at 4 sites Phase 1/2 West China Hospital · Xiamen, Fujian and 3 other locations · NCT07182565

• Tislelizumab with platinum-doublet chemotherapy followed by hypofractionated radiotherapy for stage IIIB/C–IV non-squamous NSCLC

  This trial tests whether adding Tislelizumab to platinum-doublet chemotherapy followed by hypofractionated radiotherapy can help people with stage IIIB/C–IV non‑squamous non‑small cell lung cancer who have not had prior systemic therapy.

  Recruiting Phase 2 Zibo Municipal Hospital · Zibo, Shandong · NCT07085182

• Short-course higher-dose radiotherapy plus immunochemotherapy to make gastroesophageal junction cancer removable

  This test adds short-course, higher-dose radiotherapy to PD-1 immunotherapy (sintilimab) and SOX chemotherapy for adults with locally advanced or initially unresectable gastroesophageal junction adenocarcinoma to see if tumors shrink enough for surgery.

  Recruiting at 4 sites Phase 1/2 West China Hospital · Xiamen, Fujian and 3 other locations · NCT07072351

Related topics

Quick answers

How many Hypofractionated Radiotherapy clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →